Article

COA Releases Survey Results Showing Physician Worry Over Proposed Part D Changes

In a survey released by Community Oncology Alliance (COA), the majority of physicians reported concern over proposals to reform the Medicare Part B program

In a survey released by Community Oncology Alliance (COA), the majority of physicians reported concern over proposals to reform the Medicare Part B program. The survey included 100 oncologists/hematologists and 50 rheumatologists. COA commissioned the survey to gain insight into physician perspectives of 2 proposals set forth by the Medicare Payment Advisory Commission and mentioned by President Donald Trump in his blueprint to lower drug prices and out-of-pocket costs.

The survey inquired about opinions on the revamped Competitive Acquisition Program, in which select private vendors would negotiate drug prices with manufacturers, and a proposal to shift prescription drugs currently paid under Medicare Part B into the Medicare Part D program.

Physicians indicated that they are worried the proposed changes would reduce care choices, increase costs and administrative burden, and decrease physician autonomy.

See more survey results and the full release here.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Dr Margrit Wiesendanger
Ibrahim Aldoss, MD, associate professor, City of Hope
Manmeet Ahluwalia, MD, MBA, FASCO, chief of medical oncology, chief scientific officer, and deputy director of the Miami Cancer Institute of Baptist Health South Florida
Ali Khawar
Cathy Eng, MD, FACP, FASCO
Ali Khawar
Emma Achola-Kothari, PhD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo